Kaplan-Meier analysis showing the overall survival in the 2 groups. OS was significantly better in the RIC group at 94% compared with 53% in the MAT group. Non-SCID patients in the MAT group did worse, with an overall survival of 46% compared with 96% in the RIC group. CyA indicates cyclosporin A..